Similar Papers

Paper Title
Journal
Date
Author
Development of T cell receptor-engineered T cells targeting the sarcoma-associated antigen papillomavirus binding factor.
Shuto Hamada ... Makoto Emori
Cancer science | VOL. 115
Shuto Hamada, et. al.Shuto Hamada ... Makoto Emori
25 Oct 2023
Papillomavirus binding factor (PBF)-mediated inhibition of cell growth is regulated by 14-3-3β
Nadine Sichtig ... Gertrud Steger
Archives of Biochemistry and Biophysics | VOL. 464
Nadine Sichtig, et. al.Nadine Sichtig ... Gertrud Steger
07 May 2007
Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma
Tomohide Tsukahara ... Noriyuki Sato
Cancer Science | VOL. 99
Tomohide Tsukahara, et. al.Tomohide Tsukahara ... Noriyuki Sato
01 Feb 2008
Identification of human autologous cytotoxic T-lymphocyte-defined osteosarcoma gene that encodes a transcriptional regulator, papillomavirus binding factor.
Tomohide Tsukahara ... Yoshihiko Hirohashi
Cancer Research | VOL. 64
Tomohide Tsukahara, et. al.Tomohide Tsukahara ... Yoshihiko Hirohashi
01 Aug 2004
View more papers

More From: Journal of Immunotherapy

Paper Title
Journal
Date
Author
The Effectiveness of Adjuvant PD-1 Inhibitors in Patients With Surgically Resected Stage III/IV Acral Melanoma.
Haci Arak ... Şaziye Burçak Yayla
Journal of Immunotherapy | VOL. 47
Haci Arak, et. al.Haci Arak ... Şaziye Burçak Yayla
11 Mar 2024
Clinical Outcomes of PD-1/PD-L1 Inhibitors Among Patients With Advanced or Metastatic Non-Small Cell Lung Cancer With BRAF, ERBB2/HER2, MET , or RET Alterations: A Systematic Literature Review.
Katherine G Akers ... Ashwini Arunachalam
Journal of Immunotherapy | VOL. 47
Katherine G Akers, et. al.Katherine G Akers ... Ashwini Arunachalam
19 Dec 2023
LOXL4 Shuttled by Tumor Cells-derived Extracellular Vesicles Promotes Immune Escape in Hepatocellular Carcinoma by Activating the STAT1/PD-L1 Axis.
Le Zhao ... Ruifeng Pei
Journal of Immunotherapy | VOL. 47
Le Zhao, et. al.Le Zhao ... Ruifeng Pei
04 Dec 2023
Multiple Eruptive Keratoacanthomas Secondary to Nivolumab Immunotherapy.
Eric Olsen ... Marjorie Montanez-Wiscovich
Journal of Immunotherapy | VOL. 47
Eric Olsen, et. al.Eric Olsen ... Marjorie Montanez-Wiscovich
27 Nov 2023
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.